2H-Pyran-3(4H)-one, dihydro- → 3-(2,4,5-Trifluorophenyl)-1,4,5,7-tetrahydropyrano[3,4-c]pyrazole

HRID 18477

반응식

HRID 18477 반응식
[F:1][C:2]1[CH:3]=[C:4]([C:9]2[C:13]3[CH2:14]N(C(OC(C)(C)C)=O)C[CH2:17][C:12]=3[NH:11][N:10]=2)[CH:5]=[CH:6][C:7]=1[F:8].O1CCC[C:27](=[O:31])C1.[F:32]C1C=C(F)C(F)=CC=1C(Cl)=O>>[F:32][C:5]1[CH:6]=[C:7]([F:8])[C:2]([F:1])=[CH:3][C:4]=1[C:9]1[C:13]2[CH2:14][CH2:27][O:31][CH2:17][C:12]=2[NH:11][N:10]=1

참가 물질

4

실험 절차

Intermediate 16D was prepared according to the procedure for the synthesis of intermediate 15 by replacing 1-Boc-4-piperidone with dihydro-2H-pyran-3(4H)-one, and replacing 3,4-difluorobenzoyl chloride with 2,4,5-trifluorobenzoyl chloride. LCMS (+ESI) m/z=255 [M+H]+.

출처 및 근거

ORD 기록
ord-36dedcaa54664e099a65833376c16631
출처 데이터셋
uspto-grants-2010_06
특허 번호
US07741350B1

연결된 노트

불러오는 중…